Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases

NCT04839315 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04839315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Terminated
Start date
February 15, 2021
Completion date
February 9, 2022
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, arthritis of multiple sites associated with inflammatory bowel disease (diagnosis), gout, inflammatory myositis, osteoarthritis, psoriatic arthritis, sjogren's syndrome, systemic lupus erythematosus